Exhibit 107
Calculation of Filing Fee Tables
Form S-1 (Form Type)
OncoSec Medical Incorporated
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Proposed Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||||||||||
| Fees to be Paid | Equity | Common Stock, $0.0001 par | Rule 457(o) | $ | 12,500,000 | $ | 0.00011020 | $ | 1,377.50 | |||||||||||||||||||||||
| Equity | Common Stock Warrants(4) | Rule 457(g) | — | $ | 0.00011020 | — | ||||||||||||||||||||||||||
| Equity | Common Stock Stock | Rule 457(o) | $ | 12,500,000 | $ | 0.00011020 | $ | 1,377.50 | ||||||||||||||||||||||||
| Equity | Pre-Funded Warrants(3)(4)(7) | Rule 457(g) | — | $ | 0.00011020 | — | ||||||||||||||||||||||||||
| Equity | Common Stock Underlying Pre- Funded Warrants(2)(8) | Rule 457(o) | — | $ | 0.00011020 | — | ||||||||||||||||||||||||||
| Fees Previously Paid | ||||||||||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||
| Total Offering Amounts | $ | 25,000,000 | $ | 0.00011020 | $ | 2,755.00 | ||||||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||||||||||
| Total Fees Offsets | — | |||||||||||||||||||||||||||||||
| Net Fee Due | $ | 2,755.00 | ||||||||||||||||||||||||||||||
| (1) | Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended. |
| (2) | Pursuant to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, distributions, recapitalizations or other similar transactions. |
| (3) | The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $12,500,000. |
| (4) | No fee required pursuant to Rule 457(g) under the Securities Act. |
| (5) | Represents shares of common stock issuable upon exercise of the Common Stock Warrants. |
| (6) | As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act and based on an assumed per-share exercise price for the Common Stock Warrants of 100% of the public offering price of the common stock and Pre-Funded Warrants; the proposed maximum aggregate offering price of the common stock and pre-funded warrants is $12,500,000 |
| (7) | The registrant may issue pre-funded warrants to purchase common shares in the offering. The purchase price of each pre-funded warrant will equal the price per share at which shares of common shares are being sold to the public in this offering, minus $0.0001, which constitutes the pre-funded portion of the exercise price, and the remaining unpaid exercise price of the pre-funded warrant will equal $0.0001 per share (subject to adjustment as provided for therein). |
| (8) | Represents shares of common stock issuable upon exercise of the Pre-Funded Warrants. |
